Sunday, March 2, 2008

Thesis/Research Study: " Cause and Effect of Alzheimer's Disease"

In Partial Fulfillment of the secondary courses

Requirements for graduation

S.Y 2007-2008

This Research Study is presented to the School’s Academic Affairs, Researchers’ and Curriculum of Mary Immaculate Academy

of Quezon City

Title: “Cause and Effect o Alzheimer’s Disease”

Presented By:

Hazzel Mae Mejias Cutora

IV-St. Mary

Presented to:

Ms. Joan Dia dela Cruz

March 3, 2008

Approval sheet

The research paper attached hereto entitled “Cause & Effect of Alzheimer’s disease” and submitted by Hazzel Mae Mejias Cutora in a partial fulfillment of the requirement for graduation is hereby accepted.

______________________

Mrs. Malou O. Ongoco

Asst. Principal H.S Department

Accepted in partial fulfillment of the requirements for graduating in secondary level.

___ ________________

Joan Dia Dela Cruz

Research Teacher

contents

Pages

Approval sheet...........................................................

i

TABLE OF CONTENTS.....................................................

ii

Acknowledgement.....................................................

iii

CHAPTER

1 THE PROBLEMS AND ITS BACKGROUND

1

Statement of the problem.............................................

4

Theoretical/Conceptual framework...........................

5

Hypotheses.....................................................................

8

Significance of the study..............................................

9

Scope & limitations of the study...................................

10

Definitions of key terms..................................................

10

General organization & coverage of the study.........

12

2 REVIEW OF RELATED LITERATURE

15

Related Reading............................................................

15

Related Literature...........................................................

21

Related Studies...............................................................

31

Justification of the present study..................................

32

3 METHODOLOGY

39

Research Design.............................................................

39

Locale & Population......................................................

40

Description of Respondents..........................................

40

Sampling Design............................................................

41

Random Sampling..........................................................

41

Statistical treatment.......................................................

41

Instrumentation and Try-out Phase..............................

42

4 RESULTS, ANALYSIS AND INTERPRETATION

44

5 SUMMARY,CONCLUSIONS AND RECOMMENDATIONS

49

Bibliography

Curriculum Vitae






Acknowledgement

I, Hazzel Mae Mejias Cutora would like to acknowledge or thank with gratitude to the following persons without their help and support this study would not be made possible.

First of all, I would like to give thanks our Lord God Almighty, who gave me courage, strength, knowledge and wisdom in order to attain in my goal and making all things possible.

Next, I want to thank also to my parents, brother, sister and relatives who encouraging me to finish this research study and helped me become the person I am today. Especially to my Mother Analiza C. Kawataki who is my inspiration in all of the school works that I am doing. For the people who guided and helping me out, thank you so much.

Thanks to Miss Joan Dia dela Cruz as our subject teacher in thesis who’s willing to help me .For her advices, suggestions and guidance for making this study.

To my friends, for –Hardvard- thanks a lot for accepting me as whom I am.

I love you all.

Finally, I would like to thank all persons who especially all the authors who have contributed to the finishing of this study; for without helping her I our own little ways this study would not be possible.

-- Hazzel Mae Mejias Cutora




Chapter 1

The problem and its background

Introduction

Dementia is a brain disorder that seriously affects a person’s ability to

carry out daily activities. The most common form of dementia among

older people is Alzheimer’s disease (AD), which initially involves the parts

of the brain that control thought, memory, and language.

Although scientists are learning more every day, right now they still do

not know what causes AD, and there is no cure. Scientists think that as

many as 4.5 million Americans suffer from AD. The disease usually begins

after age 60, and risk goes up with age. While younger people also may

get AD, it is much less common. About 5 percent of men and women

ages 65 to 74 have AD, and nearly half of those age 85 and older may

have the disease. It is important to note, however, that AD is not a normal

part of aging.

AD is named after Dr. Alois Alzheimer, a German doctor. In 1906, Dr.

Alzheimer noticed changes in the brain tissue of a woman who had died

of an unusual mental illness. He found abnormal clumps (now called

amyloid plaques) and tangled bundles of fibers (now called neurofibrillary

tangles). Today, these plaques and tangles in the brain are considered

signs of AD. Scientists also have found other brain changes in people with

AD. Nerve cells die in areas of the brain that are vital to memory and

other mental abilities, and connections between nerve cells are

disrupted. There also are lower levels of some of the chemicals in the brain

that carry messages back and forth between nerve cells. AD may impair

thinking and memory by disrupting these messages.

One theory is that they block nerve cells’ ability to communicate with

each other, making it difficult for the cells to survive.

Autopsies have shown that most people develop some plaques and

tangles as they age, but people with Alzheimer’s develop far more than

those who do not develop the disease. Scientists still don’t know why

some people develop so many compared to others. However, several risk

factors for Alzheimer’s disease have been uncovered.

Advancing age is the number one risk factor for developing Alzheimer’s

disease. One out of eight people over the age of 65 has Alzheimer’s

disease, and almost one out of every two people over the age of 85 has

Alzheimer’s. The probability of being diagnosed with Alzheimer’s nearly

doubles every five years after age 65.

People who have a parent or sibling that developed Alzheimer’s disease

are two to three times more likely to develop the disease than those with

no family history of Alzheimer’s. If more than one close relative has been

affected, the risk increases even more.

Scientists have identified two kinds of genes that are associated with this

familial risk factor. The first is thought to be a “risk gene,” APOE-e4, that

increases the likelihood of developing Alzheimer’s, but does not

guarantee it. In addition to APOE-e4, scientists think there could be up to

a dozen more risk genes yet to be discovered.

The second kind of gene is a “deterministic gene” and is much rarer than

risk genes. Deterministic genes are only found in a few hundred extended

families around the world. If a deterministic gene is inherited, the person

will undoubtedly develop Alzheimer’s, probably at a much earlier age.

Although age and family history are out of our control, scientists have also

identified several lifestyle factors that can influence a person’s risk of

developing Alzheimer’s disease. A connection has been found between

serious head injury and future development of Alzheimer’s, so those who

practice safety measures such as wearing seat belts and not engaging in

activities where there is a high risk of falling are at an advantage.

Evidence is also mounting for the promotion of exercise and a healthy

diet to reduce Alzheimer’s risk. Avoiding tobacco, limiting alcohol

consumption, staying socially active, and engaging in intellectually

stimulating activities have also been shown to have a protective effect

against Alzheimer’s disease.

Finally, there is a strong link between heart health and brain health. Those

who are free of heart disease or related conditions are at a lower risk of

developing Alzheimer’s or another kind of dementia than those who have

cardiovascular problems.

Statement of the Problem

This research aimed to determine the Cause and Effect of Alzheimer’s Disease.

AD develops slowly and is difficult to diagnose. Cognitive deficits

vary between patients, and correlate to the amount of education and

social interaction the patient has experienced in his or her lifetime. Poor

performance on an IQ test, for example, may reflect a lower level of

education, and not Alzheimer's disease. Thus it is necessary to have a well-

documented patient history (mental as well as physical) and this is not

always available.

it is difficult to obtain accurate histochemical information, which

would require observation of brain samples during different phases of

the disease. However, neurological biopsies are ethically questionable,

and brain dissection can only be performed post-mortem.

The goal of AD research is ultimately to identify the most effective

strategies for preventing and treating AD in diverse populations.

Recent research findings have provided an unprecedented base of

knowledge upon which to design these strategies. Research on AD

genetics, on the basic cellular biology of AD-related pathways, the

changes taking place in the brains of persons with mild cognitive

impairment and early.

AD, animal models, and hints of possible risk and protective factors from

epidemiology studies, have all contributed to identification of new

clinical opportunities. These diverse and productive research approaches

will continue to drive the design of innovative pilot studies and full scale

clinical trials that are most likely to yield effective strategies for

preventing and treating AD.

Theoretical/ Conceptual Framework

Discovery supports theory of Alzheimer's disease as form of diabetes

Insulin, it turns out, may be as important for the mind as it is for the body.

Research in the last few years has raised the possibility that Alzheimer’s

memory loss could be due to a novel third form of diabetes.

Now scientists at Northwestern University have discovered why brain insulin

signaling -- crucial for memory formation -- would stop working in

Alzheimer’s disease. They have shown that a toxic protein found in the

brains of individuals with Alzheimer’s removes insulin receptors from nerve

cells, rendering those neurons insulin resistant.

With other research showing that levels of brain insulin and its related

receptors are lower in individuals with Alzheimer’s disease, the

Northwestern study sheds light on the emerging idea of Alzheimer’s being

a “type 3” diabetes.


The new findings, published online by the FASEB Journal, could help

researchers determine which aspects of existing drugs now used to treat

diabetic patients may protect neurons from ADDLs and improve insulin

signaling in individuals with Alzheimer’s.
In the brain, insulin and insulin receptors are vital to learning and memory.

When insulin binds to a receptor at a synapse, it turns on a mechanism

necessary for nerve cells to survive and memories to form. That Alzheimer’s

disease may in part be caused by insulin resistance in the brain has

scientists asking how that process gets initiated.

“We found the binding of ADDLs to synapses somehow prevents insulin

receptors from accumulating at the synapses where they are needed,”

said William L. Klein, professor of neurobiology and physiology in the

Weinberg College of Arts and Sciences, who led the research team.

“Instead, they are piling up where they are made, in the cell body, near

the nucleus. Insulin cannot reach receptors there. This finding is the first

molecular evidence as to why nerve cells should become insulin resistant

in Alzheimer’s disease.”


ADDLS are small, soluble aggregated proteins. The clinical data strongly

support a theory in which ADDLs accumulate at the beginning of

Alzheimer’s disease and block memory function by a process predicted to

be reversible.


In earlier research, Klein and colleagues found that ADDLs bind very

specifically at synapses, initiating deterioration of synapse function and

causing changes in synapse composition and shape. Now Klein and his

team have shown that the molecules that make memories at synapses –

insulin receptors -- are being removed by ADDLs from the surface

membrane of nerve cells.

“We think this is a major factor in the memory deficiencies caused by

ADDLs in Alzheimer’s brains,” said Klein, a member of Northwestern’s

Cognitive Neurology and Alzheimer's disease Center. “We’re dealing with

a fundamental new connection between two fields, diabetes and

Alzheimer’s disease, and the implication is for therapeutics. We want to

find ways to make those insulin receptors themselves resistant to the

impact of ADDLs. And that might not be so difficult.”

Using mature cultures of hippocampal neurons, Klein and his team studied

synapses that have been implicated in learning and memory

mechanisms. The extremely differentiated neurons can be investigated at

the molecular level. The researchers studied the synapses and their insulin

receptors before and after ADDLs were introduced.

They discovered the toxic protein causes a rapid and significant loss of

insulin receptors from the surface of neurons specifically on dendrites to

which ADDLs are bound. ADDL binding clearly damages the trafficking of

the insulin receptors, preventing them from getting to the synapses. The

researchers measured the neuronal response to insulin and found that it

was greatly inhibited by ADDLs.

“In addition to finding that neurons with ADDL binding showed a virtual

absence of insulin receptors on their dendrites, we also found that

dendrites with an abundance of insulin receptors showed no ADDL

binding,” said co-author Fernanda G. De Felice, a visiting scientist from

Federal University of Rio de Janeiro who is working in Klein’s lab. “These

factors suggest that insulin resistance in the brains of those with

Alzheimer’s is a response to ADDLs.”

“With proper research and development the drug arsenal for type 2

diabetes, in which individuals become insulin resistant, may be translated

to Alzheimer’s treatment,” said Klein. “I think such drugs could supercede

currently available Alzheimer’s drugs.”



Hypothesis:

Alzheimer’s disease is a progressive and fatal brain disease.

Significance of the Study

I made this research to inform the people what Alzheimer’s disease is, and

what causes the Alzheimer’s disease. Alzheimer’s disease is conditions that

cause memory loss. I want to help the people to know about this disorder

all about. Alzheimer’s disease is a brain condition in which it affects the

brain and memory. The people who will be reading with my thesis will

understand better on what I am saying about this topic. There are a

number of terms that are crucial to be understanding of Alzheimer’s

disease This thesis includes the symptoms, the ability to remember things

and recall them at the right time. The treatment of Alzheimer’s disease

on how to cure this disease. In general, Alzheimer disease more frequently

involves deficits in new learning or recent memory.

Alzheimer's disease (AD) is the most common form of dementia among

older people. Dementia is a brain disorder that seriously affects a person's

ability to carry out daily activities. The researcher as this will inform people

how important having an Alzheimer’s disease, not only elders individual

but also young people.

Scope and Limitations

This study focused on the cause and effect of Alzheimer’s disease among

elders and also young people. Alzheimer’s disease eventually affects all

aspects of a person's life: how he or she thinks and acts. Since individuals

are affected differently, it is difficult to predict the symptoms each person

will have, the order in which they will appear, or the speed of the disease's

progression.

Definition of Key terms

Plaques – deposits of the protein beta-amyloid that accumulate in the

spaces between nerve cells

Tangles – deposits of the protein tau that accumulate inside of nerve

Cells

Insulin- is an animal hormone whose presence informs the body's cells

that the animal is well fed, causing liver and muscle cells to take in

glucose and store it in the form of glycogen, and causing fat cells to

take in blood lipids and turn them into triglycerides. In addition it has

several other anabolic effects throughout the body.

Diabetes mellitus -is a syndrome characterized by disordered

metabolism and inappropriately high blood sugar (hyperglycemia)

resulting from either low levels of the hormone insulin or from abnormal

resistance to insulin's effects coupled with inadequate levels of insulin

secretion to compensate abnormal clumps (now called

amyloid plaques) and tangled bundles of fibers (now called neurofibrillarytangles)

Head injury -is any trauma that leads to injury of the scalp, skull, or brain.

The injuries can range from a minor bump on the skull to serious brain

injury.

Alzheimer's Disease- A progressive, degenerative disease of the brain that

leads to dementia. Many think that Alzheimer's disease and dementia are

the same thing, but Alzheimer's is actually the most common cause of

dementia. While everyone who has Alzheimer's develops dementia, not

everyone who develops dementia has Alzheimer's disease.

AD- is an abbreviation of “Alzheimer's Disease”.

Dementia- A general term that describes a brain syndrome characterized

by problems with memory, judgment, language, orientation, and

executive functioning. Alzheimer's disease is the most common cause of

dementia, but dementia can also be caused by strokes, Parkinson's

disease, head injury, or a host of other conditions -- very few of which are

reversible.

ADDL - the protein, known to attack memory-forming synapses, is called an ADDL for “amyloid Ăź-derived diffusible ligand.”)

ADDLS - are small, soluble aggregated proteins.

The Alzheimer’s Disease Association of the Philippines (ADAP)-

founded in March 2000 and a member of the Alzheimer’s Disease

International in 2002, is an organization composed of persons with

dementia and their family caregivers, dedicated doctors with special

interest in dementia, allied –medical professionals and others involved

in the care of patients. It is the mission of ADAP to assist families

through educational programs and support services to optimize quality

of life for afflicted individuals and their families; to raise awareness

about dementia; to promote advocacy for elderly quality care; and to

support research in dementia

General Organization and coverage of the study

Alzheimer’s disease (AD) is the most common type of neurodegenerative

disorder in the aging population, with dementia as a common

consequence. AD is defined pathologically by the appearance of

extracellular senile plaques and intracellular neurofibrillary tangles, as

described by Alois Alzheimer about a century ago. The causes for AD

include genetic predisposition in a small population, aging and

environmental stresses in majority cases. The underlying pathogenic

cascades, increases in expression of amyloid precursor protein and and

reactive oxidant activity and inflammation, havebaccumulation of A the

features of both adaptive, at least initially, and harmful when becoming

excessive.


Dementia, on the other hand, is a clinical diagnosis and is defined as

globally, persistently impaired cognitive skills including memory. Alzheimer

dementia refers to clinical dementia in patients who also have Alzheimer

neuropathology. Alzheimer dementia is what brings the patients to seek

medical treatments. An extraordinary inability to form new memory,

especially of those episodic type, and executive dysfunction are among

the earliest symptoms in AD patients. In end-stage AD, cognitive

degeneration extends far beyond memory loss. The underlying causes

include decreases in impaired brain metabolism, which results in impaired

synaptic functions and capacities, thus impaired information processing,

and eventually leads to neuronal injury and death.

Early-stage is the early part of Alzheimer’s disease when problems with

memory, thinking and concentration may begin to appear in a doctor’s

interview or medical tests. Individuals in the early-stage typically need

minimal assistance with simple daily routines. At the time of a diagnosis, an

individual is not necessarily in the early stage of the disease; he or she may

have progressed beyond the early stage.

The term early-onset refers to Alzheimer's that occurs in a person under

age 65. Early-onset individuals may be employed or have children still

living at home. Issues facing families include ensuring financial security,

obtaining benefits and helping children cope with the disease. People

who have early-onset dementia may be in any stage of dementia – early,

middle or late. Experts estimate that some 500,000 people in their 30s, 40s

and 50s have Alzheimer's disease or a related dementia.

CHAPTER II

REVIEW OF RELATED LITERATURE

Foreign Literature

All too frequently, people are discovering that a grandparent, parent,

elderly relative, or friend can no longer remember names or faces,

recognize common objects, or talk in coherent sentences. This person

may be suffering from Alzheimer's disease (AD). Alzheimer's disease is a

growing medical and social concern. Zaven Khachaturian and Teresa

Radebaugh, in their 1996 book Alzheimer's disease: Cause(s), Diagnosis,

Treatment, and Care, state that AD strikes more than 4 million people in

the United States alone and affects millions more who suffer from

watching a loved one afflicted with the disease. In the last 30 years, AD

has become a hot topic in both the medical and non-medical

communities.

Khachaturian and Radebaugh describe AD as a "degenerative disorder

that attacks the brain and leads to dementia." The brain's cognitive

centers are affected, causing memory loss and the inability to understand

situations or even questions or statements. As the disease progresses,

social interactions diminish, and the afflicted person loses the ability to

care for him or herself.

The duration of AD, from onset to death, ranges from two to 20 years.

Symptoms of AD will often become noticeable between the ages of 65

and 85, becoming more prevalent as the person grows older and the

disease progresses. Although rare, AD can manifest as early as age 45,

and is termed "early onset" Alzheimer's disease when it occurs before 65.

Scientists do not yet fully understand what causes AD. There probably is

not one single cause, but several factors that affect each person

differently. Age is the most important known risk factor for AD. The number

of people with the disease doubles every 5 years beyond age 65.

Family history is another risk factor. Scientists believe that genetics may

play a role in many AD cases. For example, early-onset familial AD, a rare

form of AD that usually occurs between the ages of 30 and 60, is inherited.

The more common form of AD is known as late-onset. It occurs later in life,

and no obvious inheritance pattern is seen in most families. However,

several risk factor genes may interact with each other and with non-

genetic factors to cause the disease. The only risk factor gene identified

so far for late-onset AD is a gene that makes one form of a protein called

apolipoprotein E (ApoE). Everyone has ApoE, which helps carry

cholesterol in the blood. Only about 15 percent of people have the form

that increases the risk of AD. It is likely that other gene

also may increase the risk of AD or protect against AD, but they remain to

be discovered.

Scientists still need to learn a lot more about what causes AD.

In addition to genetics and ApoE, they are studying education, diet, and

environment to learn what role they might play in the development of this

disease. Scientists are finding increasing evidence that some of the risk

factors.

AD begins slowly. At first, the only symptom may be mild forgetfulness,

which can be confused with age-related memory change. Most people

with mild forgetfulness do not have AD. In the early stage of AD, people

may have trouble remembering recent events, activities, or the names of

familiar people or things. They may not be able to solve simple math

problems. Such difficulties may be a bother, but usually they are not

serious enough to cause alarm.

However, as the disease goes on, symptoms are more easily noticed and

become serious enough to cause people with AD or their family members

to seek medical help. Forgetfulness begins to interfere with daily activities.

People in the middle stages of AD may forget how to do simple tasks like

brushing their teeth or combing their hair. They can no longer think clearly.

They can fail to recognize familiar people and places. They begin to

have problems speaking, understanding, reading, or writing. Later on,

people with AD may become anxious or aggressive, or wander away

from home. Eventually, patients need total care.

An early, accurate diagnosis of AD helps patients and their families plan

for the future. It gives them time to discuss care while the patient can still

take part in making decisions. Early diagnosis will also offer the best

chance to treat the symptoms of the disease.

Today, the only definite way to diagnose AD is to find out whether there

are plaques and tangles in brain tissue. To look at brain tissue, however,

doctors usually must wait until they do an autopsy, which is an

examination of the body done after a person dies. Therefore, doctors can

only make a diagnosis of “possible” or “probable” AD while the person is

still alive.

At specialized centers, doctors can diagnose AD correctly up to 90

percent of the time. Doctors use several tools to diagnose “probable” AD, including:

  • questions about the person’s general health, past medical

problems, and ability to carry out daily activities,

  • tests of memory, problem solving, attention, counting, and

language,

  • medical tests—such as tests of blood, urine, or spinal fluid, and
  • brain scans.

Sometimes these test results help the doctor find other possible causes of

the person’s symptoms.

For example, thyroid problems, drug reactions, depression, brain tumors,

and blood vessel disease in the brain can cause AD-like symptoms. Some

of these other conditions can be treated successfully.

The National Institute on Aging (NIA), part of the National Institutes of

Health (NIH), is the lead Federal agency for AD research. NIA-supported

scientists are testing a number of drugs to see if they prevent AD, slow the

disease, or help reduce symptoms. Researchers undertake clinical trials to

learn whether treatments that appear promising in observational and

animal studies actually are safe and effective in people. Some ideas that

seem promising turn out to have little or no benefit when they are

carefully studied in a clinical trial.

Scientists are finding that damage to parts of the brain involved in

memory, such as the hippocampus, can sometimes be seen on brain

scans before symptoms of the disease occur. An NIA public-private

partnership—the AD Neuroimaging Initiative (ADNI)—is a large study that

will determine whether magnetic resonance imaging (MRI) and positron

emission tomography (PET) scans, or other imaging or biological markers,

can see early AD changes or measure disease progression. The project is

designed to help speed clinical trials and find new ways to determine

the effectiveness of treatments.

Cholesterol is widely blamed for causing Alzheimer's disease. Yet little is

known about the relationship between cholesterol and Alzheimer's, and

one hypothesis, described below, is that cholesterol protects the brain

from Alzheimer's. It is unsurprising that, when one of the most booming

industries is the sale of cholesterol-lowering drugs, just about every disease

under the sun would be pinned to cholesterol. The more diseases blamed

on cholesterol, the more profits generated by the sale of cholesterol-

lowering drugs.

But is it true that cholesterol causes Alzheimer's disease? Or, on the other

hand, could you actually harm your brain by reducing its cholesterol

content through drugs or a low-fat, low-cholesterol diet? And if cholesterol

isn't to blame, what does cause Alzheimer's, and what is the best way to

protect ourselves from it? Headlines blaming cholesterol for Alzheimer's

disease abound. A Google search for "cholesterol and the brain" turns up

such titles as "Cholesterol central to brain disease," and "Cholesterol bad

for brain, too." One study bragged that by using stains, cholesterol-

lowering drugs, medical researchers could reduce the amount of

cholesterol in the brains of Alzheimer's patients with normal cholesterol

levels by an average of 21.4 percent. Without studying whether this drop

in cholesterol resulted in improved memory or other cognitive effects, the

study celebrated the ability to reduce normal levels of brain cholesterol

based on the dubious notion that cholesterol is "involved" in the formation

of amyloidal plaques, a hallmark of Alzheimer's disease.

Since the brain, being only 2% of the body's weight, yet containing a full

25% of its cholesterol, relies on cholesterol as so necessary and central to

its function, it is not very surprising that cholesterol would be "involved" in

any brain disorder.

Local Literature


A terrifying disease indeed, Alzheimer's has to this date caused confusion

and much speculation in the medical world. What is Alzheimer's? How

does it occur? How can it be detected? Who is most susceptible to

contract it? All of these are common questions doctors and medical

researchers ponder on; questions that are investigate the fundamental

roots of Alzheimer's [as well as other diseases]. With these questions being

unanswered, it can be only known that Alzheimer's exists and takes over

the lives of approximately 4% of Philippines‘s elderly population every year

with the number on the rise.

Alzheimer's is a terrible disease that is growing in numbers every single

year. People over the age of 65 are the ones that need to worry most

about getting it, yet some people that are younger can still get it. This

disease is a terrible disease and can be scary and frustrating. Doctors

have a very difficult time diagnosing it because there are so many things

that are similar to this disease. This disease not only destroys the lives of the

victims, but also can ruin the lives of the people that take care of them. At

this time there is not a cure, but many scientists are working very hard to

find a cure for this terrible disease. Today there are almost 2 million Filipinos

that suffer from Alzheimer's disease. It is estimated that this disease will

claim 14 million victims by the year 2050. Experts believe this because of

greater life expectancy . Meanwhile, almost 4 percent of

Filipinos between the ages of 65 to 74 will get this disease. For the people

between the ages of 75 through 84 it is expected to strike ten percent,

and people over the age of 85 have a 17 percent chance of contracting

this horrifying disease. It can also strike the lives of people in their forties or

fifties, although this is not that common. Undeniably, Alzheimer's is an

extremely terrible disease to get because one loses memory, self-pride,

and independence to care for one's self. Because so little information is

known about this disease by the public and even medical experts, it is

described as a "silent disease".

In 1906 a German psychiatrist and neuropathologies by the name of Dr.

Alois Alzheimer discovered and named this disease. He had a female

patient that was experiencing memory loss, confusion, depression, and

hallucinations. She died in a nursing home at the age of 55. Dr. Alzheimer

wanted to conduct an autopsy to see if he could figure out exactly what

had caused her mysterious death. He discovered "two startling

abnormalities, inside and outside the brain cells." Tissue lying inside the cell

bodies or nuclei of neurons exhibited an abnormally high number of fine

nerve fibers or filaments, twisted around each other. He called these

twisted fibers neurofibrillary tangles. He also saw unusually high numbers of

fibrous plaques located between brain cells, composed of degenerating

terminal dendrites or burned out nerve endings that surrounded fibrous

amyloid protein. These abnormalities were known as senile or neuritic

plaques. Today there are many different theories of what causes

Alzheimer's. Some experts believe that the intake of too much aluminum

may play an important role in what causes Alzheimer's, although there is

no evidence yet .Others believe that there are "three genes that are

somehow part of the problem". Yet other scientists suspect that it could be

some sort of viral defect). Some scientists even believe that head trauma

may be the cause of this horrifying disease. Some studies showed that

people who have had head injuries in the past get this disease more than

people who have not had any head injuries. It may also be possible that

Alzheimer's disease is hereditary and passed on through the genes. Some

scientists believe that the amount of mitochondria in the cells may play an

important role in what causes Alzheimer's disease. They have found that

8.3 percent of Alzheimer's patients had a "mitochondrial DNA mutation."

This can possibly leave the brain cells "starved of energy," and in turn

cause them to die.

Alzheimer's is a terrible disease that leaves its victims confused,

disoriented, and dependent on others. It is hard for the victims to even

realize that they have the disease in the early stages. Relatives or close

friends of the victim may not even realize what is happening because it is

so gradual. They may think that the victim is acting the way they are due

to old age. The first stage of Alzheimer's can last anywhere from two to

four years. The first thing that starts to happen is usually memory loss;

victims may forget events or names. They may also have a hard time

concentrating on something or learning new things .Then they may

become confused and disoriented. Victims might get lost and forget the

day, month, and year easily. The person may have a difficult time

completing sentences when talking. He or she may be unable to follow

directions. Victims can also have a difficult time completing familiar tasks

such as cooking, cleaning, and performing their job. The victim's mood

changes and this leads to depression. Last of all they may neglect their

personal hygiene, such as brushing their teeth or taking a bath . In the

early stages of Alzheimer's there is a gradual loss of mental and physical

abilities . The victims seem to suffer physical damage to some parts of their

brain . This damage to the brain is in the form of lesions, "abnormal

changes in the brain cells themselves." Lesions can only be observed

clearly during an autopsy of the brain . These lesions are usually found in

the limbic system or other parts of the brain that help in the controlling of

memory and learning. The presence of lesions somehow disturb brain

cells, and in turn cause one to lose one's memory .

As previously stated, Alzheimer's is an extremely difficult disease to

recognize or diagnose in the early stages. Other illnesses are similar in the

way that they affect the brain and some mental disorders are also similar.

Mental confusion, irrational behavior, and loss of memory is classified

under dementia . For a doctor to find out if a patient has Alzheimer's he

must find a way to rule out possibilities of the patient having some other

"dementing illness." The doctor asks various questions about the person's

general health and present condition to help in ruling out other

"dementing illnesses" . The second stage of Alzheimer's leaves the victims

basically helpless. Their behavior can become extremely unpredictable in

some people. This stage can last from two to ten years. The victims have

continued and progressive memory loss which can make it impossible for

them to remember past and even current events .The victims may

become severely disoriented and confused. He or she may lose the ability

to recognize loved ones and even their own reflection. The victims might

wander away and get lost. The victims become unable to express

themselves and to complete sentences. They go through mood swings

and personality changes which are usually short lived. The victim may

wander around at night or repeat movements over and over. They suffer

from behavior problems and can have hallucinations. Sometimes they

hide things and then wreck things when they are trying to find the thing

they hid in the first place. Their motor activity becomes impaired and they

may have a tough time buttoning their shirt or tying their shoelace. They

may experience muscle twitching. They may also tend to lose their sense

of balance. Scientists have tried a variety of drugs to cure Alzheimer's

disease, but they have not been successful yet. There have been

hundreds of drugs tested on Alzheimer's patients, but none have been

totally successful.

Most of them were found either ineffective or caused some serious side

effects. Lecithin was one type of drug that was tried but it was found to

be ineffective. However, a drug by the name of tacrine has shown to help

a few people with Alzheimer's disease, but then more in-depth studies

showed that these benefits could not be confirmed. Various medications

may be prescribed to help with any behavior problems that the patient

might have. Medications such as antidepressants or antipsychotic are

sometimes given in small doses to patients in order to control their

behavior problems. It is rather disappointing that scientists have not found

a cure for this disease yet, but they believe that there is still hope that one

day they will find a cure. This disease can be extremely hard to live with if

one does not have any close friends or relatives. Here is a story of a man

named Andrew who had to go through this disease with no one to help

him. Andrew's wife died when he was 65. He retired from his job and

moved to a trailer park.

He did not have any children, and he didn't have any relatives that lived

close by. He also had no friends. No one knew him that well, so when he

started to show some early signs of Alzheimer's disease no one even

noticed. Some of his cousins were surprised that they didn't hear from him

over the holidays, but soon forgot about it because they were so busy

with their own lives. His neighbors started to notice that he didn't dress

neatly anymore, and that he didn't take care of his yard anymore. His

neighbors all thought that someone else should check on Andrew to see if

he needed any help. After about two years he started to wander around

outside. One morning he was found sleeping under a tree a few blocks

from his house. He was very confused and could not tell anyone where he

lived. The family that found him called the police, realizing that Andrew

was ill. They took him to the emergency room at the nearby hospital.

Finally a nurse got him to tell her his name. No relatives or close friends

could be found, so he was admitted to the hospital. He was diagnosed

with having Alzheimer's disease, but the hospital could not find anyone to

take care of him. A social worker also tried, but had no luck. He was sent

to the state mental hospital because he had some financial problems

and could not afford to stay at a nursing home. He had no choice in

deciding this. Andrew soon realized where he was and wanted to get out.

He could not afford it, so he had to stay where he was. Soon a guardian

was found for him, and took care of him until he died five years later. It is

extremely difficult to have Alzheimer's. It can be even more devastating if

the victim is not financially secure. This can make it hard to find a place to

stay. In Andrew's case, he also had no friends or relatives to help him

through it. The victims of this disease are often felt sorry for, but people

usually don't think of the people that take care of the Alzheimer's victim.


It can be very rough on the caretaker in many different ways. There is a

chance that the person taking care of the victim may feel angry or

frustrated. He may be angry that he has to deal with this problem, angry

that other family members fail to do their share. He might be angry at the

Alzheimer's victim for his unusual behavior. The caregiver may feel

embarrassed about the way that the Alzheimer's victim acts around

others that do not understand exactly what is wrong with the victim. The

caretaker may feel guilty about the way that he is acting around the

victim or for using harsh words at the victim when he loses his temper . The

caregiver might be hopeful that there will be some cure for Alzheimer's

sometime soon in the future, but yet discouraged that there is not a cure

right now and the possibility that there may not be a cure for a long time .

Taking care of a loved one with Alzheimer's can be extremely tiring and

even frustrating. It can totally change the way that a person lives his life. A

group called the "Alzheimer's Disease and Related Disorders

Association(ADRDA)", made up of mostly families of Alzheimer's victims,

helps people to get through the difficulties of being a guardian or

caretaker. This group has meetings at which members can express their

personal feelings and experiences with Alzheimer's victims. They can also

share what they do to deal with the problems that they have

encountered. It also does research to help find the causes of Alzheimer's

and a cure for this disease. This group has recently changed its name to

"Alzheimer's Association" . Alzheimer's is a terrible disease that destroys the

lives of many people and will probably destroy many more as life

expectancy increases. The victims know that the disease will slowly eat

away at the life that they have left inside of them. They also know that

there is no known cure at this time to help them overcome this terrible

disease, so they can live their life like a normal person. Offer from

Alzheimer's disease.

Alzheimer's Disease Association of the Philippines (ADAP) ... Facing the

Challenge of Alzheimer’s Disease: Dementia on the Rise, No Time to Lose.

900 – 1000.

Vision:

We the prime movers in the care of Alzheimer's Disease and Related

Disorders envision:

The Filipino people optimally addressing issues associated with Alzheimer's

Disease and related disorders, being one with the world in continuously

striving for a life that is dignified, productive, and full of hope for patients

and their families.

Mission:

To be in the forefront of increasing the level of awareness for Alzheimer's

Disease and related disorders, creating optimal support services for

patients, their families and caregivers, and providing all available support

to healthcare professionals, individuals, and institutions for the

advancement of research.

Values:

Passion for excellence

  • We demand of ourselves the highest standards in every endeavor

we will undertake.

Social Responsibility

  • We take an active role in advocating solutions that address the

needs of AD patients, their families, and their healthcare professionals

involving:

    • Legislation
    • Disease Management Guidelines
    • Public Fora and Advocacy Programs
  • We are continuously in-touch with the realities in the Philippine setting as it affects the management of AD and related disorders.
  • We work in collaboration with other sectors and organizations in addressing issues related to AD and related disorders.

Commitment

  • We willingly share precious time, expertise, and resources for the continuous growth of ADAP and realization of its vision.

Innovation

  • We continuously explore viable new and alternative approaches in attaining the ADAP Vision.
  • We maintain a critical yet an open mind in every undertaking that would lead to the attainment of the ADAP Vision.

Ethical

  • We work within the boundaries of acceptable norms and standards and we constantly seek for enlightenment on issues on preservation of the dignity of human life.

Scientific Advancement

  • We consciously share, organize, and analyze data for the advancement of the management of AD and related disorders.
  • We value the scientific process, identifying and prioritizing research for the attainment of the ADAP Vision.

Alzheimer's disease is the most common cause of dementia, which is the

loss of intellectual and social abilities severe enough to interfere with daily

functioning. Dementia occurs in people with Alzheimer's disease because

healthy brain tissue degenerates, causing a steady decline in memory

and mental abilities.

Related Studies

Alzheimer's disease was named after Alois Alzheimer, who was a

psychiatrist with a specialty in neuropathology, and was the first to show

what was going on physically in the brain of someone with what we now

call Alzheimer's. In 1907, he presented his findings from the autopsy of his

patient, Auguste D., who had been admitted to an asylum for "delerium

and frenzied jealousy of her husband."

Alois Alzheimer noted two things about the condition of Auguste's brain, to

which he attributed her mental degeneration: "miliary bodies," which we

now call "amyloid plaques," and "dense bundles of fibrils," which we now

call "neurofibrillary tangles." This was a bold claim at a time when the

connection between the physical and the mental was being explored but

not yet fully accepted, and in 1910, Alzheimer's mentor, Emil Kraepelin,

named the disease after him.1

The amyloid plaques are made up of a peptide (a peptide is a fragment

of a protein) called "beta-amyloid," which is formed by the cleavage of

amyloid precursor protein (APP) by an enzyme called "gamma-secretase."

The tangles, on the other hand, are primarily composed of a protein

called "tau," which forms tangles when it is hyper-phosphorylated. The

plaques exist on the outside of cells, while the tangles exist on the inside of

cells.

Justification of the present study

Alzheimer's disease eventually affects all aspects of a person's life: how he or she thinks and acts. Since individuals are affected differently, it is difficult to predict the symptoms each person will have, the order in which they will appear, or the speed of the disease's progression.

In general the following will be affected by the disease:

(i) Mental abilities

  • A person's ability to understand, think, remember and communicate will be affected.
  • The ability to make decisions will be reduced.
  • Simple tasks that have been performed for years will become more difficult or be forgotten.
  • Confusion and memory loss, initially for recent events and eventually for long-term events, will occur.
  • The ability to find the right words and follow a conversation will be affected.

(ii) Emotions and moods

  • A person may appear uninterested and apathetic, and may quickly lose interest in the hobbies they previously enjoyed.
  • The ability to control mood and emotion may be lost.
  • Some individuals are less expressive and are more withdrawn.
  • However, it is now becoming clear that a person even in the later stages of the disease may continue to feel a range of emotions including joy, anger, fear, love, and sadness.

(iii) Behavior

Changes will develop in the way the person reacts to his or her environment. These actions may seem out of character for the person. Some common reactions include:

  • repeating the same action or words
  • hiding possessions
  • physical outbursts
  • restlessness

(iv) Physical abilities

The disease can affect a person's physical co-ordination and mobility, leading to a gradual physical decline. This will affect the person's ability to independently perform day-to-day tasks, such as eating, bathing and getting dressed.

Signs and symptoms

  • Increasing and persistent forgetfulness, especially of recent events or simple directions, what begins as mild forgetfulness persists and worsens. People with Alzheimer's routinely misplace things, often putting them in illogical locations. They frequently forget names, and eventually, they may forget the names of family members and everyday objects.
  • Difficulties with abstract thinking. People with Alzheimer's may initially have trouble balancing their checkbook, a problem that progresses to trouble recognizing and dealing with numbers.
  • Difficulties finding the right word to express thoughts or even follow conversations. Eventually, reading and writing also are affected.
  • Disorientation to time and dates. They may find themselves lost in familiar surroundings.
  • Loss of judgment. Solving everyday problems, such as knowing what to do if food on the stove is burning, becomes increasingly difficult, eventually impossible.
  • Difficulties performing familiar and routine tasks that require sequential steps, such as cooking, become a struggle as the disease progresses. Eventually, forget how to do even the most basic things.
  • Personality changes. People with Alzheimer's may exhibit mood swings. They may express distrust in others, show increased stubbornness and withdraw socially.

causes

  • There is destruction of brain cells disrupting the transmitters that carry the messages in the brain, particularly those responsible for storing memories.
  • The cause of the destruction remains of the cells unknown.
  • Studies show that genetic factors play part in the development of the disease.
  • The neurotransmitters neither acetylcholine ‘and’ nor epinephrine are hypothesized to be hypoactive in Alzheimer's disease.

risk factors

  • Age. Alzheimer's usually affects people older than 65, but can rarely, affect those younger than 40. The average age at diagnosis is about 80. Less than 5 percent of people between 65 and 74 have Alzheimer's. For people 85 and older, that number jumps to nearly 50 percent.
  • Heredity. Your risk of developing Alzheimer's appears to be slightly higher if a first-degree relative -parent, sister or brother - has the disease.
  • Sex. Women are more likely than men are to develop the disease, in part because they leave longer.
  • Lifestyle. The same factors that put you at risk of heart diseases, such as high blood pressure and high cholesterol, may also increase the likelihood that you'll develop Alzheimer's disease. And, keeping your body fit isn't your only concern - you've got to exercise your mind as well.
  • Head injury. The observation that some ex-boxers eventually develop dementia leads to the question of whether serious traumatic injury to the head (for example, with a prolonged loss of consciousness) may be a risk factor for Alzheimer's.

How many suffer?

  • 11 million people suffer worldwide
  • About 5% of people reaching 65 are affected
  • 15-25% of people reaching 85 are affected
  • Late stage of disease requires one total dependence and inactivity representing an enormous burden on family and health care delivery

What can be done?

  • Currently there is no cure for Alzheimer's Disease
  • General treatment approach to patient is to provide supportive medical care, pharmacological treatment for specific symptoms, including disruptive behavior, and emotional support for patients and their families

We all forget things once in a while. Maybe you've forgotten to send a

card for someone's birthday or to return an overdue library book.

Forgetting stuff is a part of life and it often becomes more common as

people age.

But Alzheimer (say: alts-hi-mer) disease, which affects some older people,

is different from everyday forgetting. It is a condition that permanently

affects the brain, and over time, makes it harder to remember even basic

stuff, like how to tie a shoe.

Eventually, the person may have trouble remembering the names and

faces of family members - or even who he or she is. This can be very sad

for the person and their families. It's important to know that Alzheimer

disease does not affect kids. It usually affects people over 65 years of age.

Researchers have found medicines that seem to slow the disease down.

And there's hope that someday there will be a cure.

What Happens in the Brain?

You probably know that your brain works by sending signals. Chemical

messengers, called neurotransmitters (say: nur-oh-trans-mih-terz), allow

brain cells to communicate with each other. But a person with Alzheimer

disease has decreased amounts of neurotransmitters. People with

Alzheimer disease also develop deposits of stuff (protein and fiber) that

prevent the cells from working properly. When this happens, the cells can't

send the right signals to other parts of the brain. Over time, brain cells

affected by Alzheimer disease also begin to shrink and die.

Lots of research is being done to find out more about the causes of

Alzheimer disease. There is no one reason why people get Alzheimer

disease. Older people are more likely to get it, and the risk gets greater

the older the person gets. For instance, the risk is higher for someone who

is 85 than it is for someone who is 65. And women are more likely to get it

than men.

Researchers also think genes handed down from family members can

make a person more likely to get Alzheimer disease. But that doesn't

mean everyone related to someone who has Alzheimer disease will get

the disease. Other factors, combined with genes, may make it more likely

that someone will get the disease. Some of them are high blood pressure,

high cholesterol, Down syndrome, or having a head injury.

On the positive side, researchers believe exercise, a healthy diet, and

taking steps to keep your mind active (like doing crossword puzzles) may

help delay the onset of Alzheimer disease.

How Do People Know They Have It?

The first sign of Alzheimer disease is a continuous pattern of forgetting

things. This starts to affect a person's daily life. He or she may forget where

the grocery store is or the names of family and friends. This stage of the

disease may last for some time or quickly progress, causing memory loss

and forgetfulness to get worse.

What Will the Doctor Do?

It can be hard for a doctor to diagnose Alzheimer disease because many

of its symptoms (like memory problems) can be like those of other

conditions affecting the brain. The doctor will talk to the patient, find out

about any medical problems the person has, and will examine him or her.

The doctor can ask the person questions or have the person take a written

test to see how well his or her memory is working. Doctors also can use

medical tests (such as MRI or CT scans) to take a detailed picture of the

brain. They can study these images and look for the deposits of proteins

and fiber that are typical of Alzheimer disease.

Once a person is diagnosed with Alzheimer disease, the doctor may

prescribe medicine to help with memory and thinking. The doctor also

might give the person medicine for other problems, such as depression

(sad feelings that last a long time). Unfortunately the medicines that the

doctors have can't cure Alzheimer disease; they just help slow down the

disease.

When Someone You Love Has Alzheimer Disease

You might feel sad or angry - or both - if someone you love has Alzheimer

disease. You might feel nervous around the person, especially if he or she

is having trouble remembering important things or can no longer take

care of himself or herself.

You might not want to go visit the person, even though your mom or dad

wants you to. You are definitely not alone in these feelings. Try talking with

a parent or another trusted adult. Just saying what's on your mind may

help you feel better. You also may learn that the adults in your life are

having struggles of their own with the situation.

If you visit a loved one who has Alzheimer disease, try to be patient. He or

she may have good days and bad days. It can be sad if you no longer

are able to have fun in the same ways together. Maybe you and your

grandmother liked to go to concerts. If that's no longer possible, maybe

bring her some wonderful music on a CD and listen together. It's a way to

show her that you care - and showing that love is important even if her

memory is failing.

Chapter III

Research Methodology

Research Design

Being the researcher I employed the descriptive method. This is designed

for the investigator to gather information about present existing

conditions. The goal of Alzheimer’s disease research is ultimately to

identify the most effective strategies for preventing and treating

Alzheimer’s disease in diverse populations. Recent research findings have

provided an unprecedented base of knowledge upon which to design

these strategies. Research on Alzheimer’s disease genetics, on the basic

cellular biology of Alzheimer’s disease -related pathways, the changes

taking place in the brains of persons with mild cognitive impairment and

early Alzheimer’s disease, animal models, and hints of possible risk and

protective factors from epidemiology studies, have all contributed to

identification of new clinical opportunities. This diverse and productive

research approaches will continue to drive the design of innovative pilot

studies and full scale clinical trials that are most likely to yield effective

strategies for preventing and treating Alzheimer’s disease.

It is difficult to predict the pace of science or to know with certainty what

the future will bring. However, the progress we have already made will

help us speed the pace of discovery, unravel the mysteries of Alzheimer’s

disease’s pathology, and develop safe, effective preventions and

treatments, to the benefit of older Americans.

Locale & Population

The study was conducted at Mary Immaculate Academy of Quezon City.

The respondents were the high school students from 1st year to 4th year of

MIAQC.

Description of the Respondents

I chose sixty (60) respondents studying in MIAQC. They are aged 12 years

old to 17 years old, male and female, from all walks of life. I considered

the students of MIAQC who were able or unable to answer my survey

questionnaire for more valid reason.

Sampling Design

In order to get the respondents, probability sampling was use. In

probability sampling, the sample is a proportion ( certain %) of the

population and such sample is selected for the population by means of

systematic way in which energy element of the population has a chance

of being included in the sample. In this case, all students of MIAQC were

given equal chances of being selected as my respondents.

Random Sampling

Random sampling is one in which everyone in the population of the

inquiry has an equal chance of being selected to be included in the

sample. This is used if the population has no differentiated levels, sections

or classes. This technique is easy to understand and apply.

Statistical Treatment

Statistics play a vital role in the field applied scientific research. It provides

varied tools and techniques that help the researcher draw valid and

reliable references or generalizations about the population on the basis of

the sample.

The statistical technique that will be used to interpret data, and in testing

the null hypothesis of the study of the Percentage/Relative Frequency. The

formula for

Percentage/Relative Frequency (RF):

RF= (f/n)*100

Where: RF is the relative frequency

f is the frequency

n is the total number of respondents

Instrumentation and Try-out phase

The most important in an inquiry or research is gathering of data. This is

considered as an extremely vital stage in several statistical inquiries. Unless

suitable concern is exercised

in the means data gathered, the consequences could lead to bogus

interpretations. In choosing the sampling technique, the nature of the

problem, the objectives of the researchers, the category of data needed,

and the sources of these data must be considered.

In gathering the data, the researches used the survey interview, with the

aid of questionnaire. Survey is a fact-finding study with adequate and

accurate interpretation used to collect demographic data about

people’s behavior, practices, intentions, beliefs, attitudes, opinions, and

the like and then such data are analyzed, organized and

interpreted. Questionnaire is the most common and widely used method

in gathering data regarding the attitudes and opinions of a group of

persons, through personal interview.

A pretest or try-out phase was conducted to test the questionnaires

validity and if the questions was clearly conducted.

The try-out phase was conducted on January 21-23 2008.

Chapter IV

Presentation, analysis and Interpretation of data

This chapter presents the analysis and interpretation of the gathered data.

I based the interpretation from the responses of the high school students

of MIAQC. The answers were tabulated, by giving each answer its

corresponding percentage.

To obtain the correct tabulation, I included the total number of

respondents and made sure that the total percentage would be equal.

The interpretation of the researcher would be found at the bottom of

every tables and charts. The respondents’ answers to the question were

analyzed and studied carefully and interpreted objectively.

Table 1

Age of the respondents

Age

Number

Percent

12-13

14-15

16-17

23

24

13

38%

40%

22%

Total 60 100%

The table and bar graph shows the distribution of the population by age.

23 out of 60 respondents or 38% belongs to 12-13 age bracket, 24 or 40%

belongs to 14-15 years old; students belonging to 16-17 years old

constituted 22% of the total population.

Table 2

Gender of the respondents

Gender

Number

Percent

Male

Female

22

38

37%

63%

Total 60 100%

The table shows the gender of the respondents 22 of them or 37%

are males and 38 students or 63% are females.

Table 3

Answering the survey questionnaire

This pie shows how the students of MIAQC answer my survey

questionnaire. 70% or 42 students who did answer my survey

questionnaire seriously. 30% or 18 students of MIAQC who DIDN’T answer

my survey questionnaire seriously. You know who you are guys.

I surveyed some high school students of MIAQC and tried to gain data

from their response. These are the questions used in the survey and the

percentage of respondents according to their response.

Table 4

Overall Respondents

Questions

Number

Percent

Number

Percent

Yes

No

  1. Do you know what Alzheimer’s disease is? If yes, how? If no, why?

51 85%

9 15%

  1. Do you know the effect of Alzheimer’s disease to a person?

42 70%

18 30%

  1. Are you familiar with the causes of Alzheimer’s disease?

31 52%

29 48%

  1. Where did you get the information about the said topic?

_____ peers _____ books

_____ Internet _____ other (please specify) ____________

Where did you get the information about the said topic?

Number

Percent



Peers

11

18%


Internet

10

17%


Books

17

28%


Others: Relatives, Family members, chart, ads, TV

22

37%


  1. What was your reaction upon learning about the disease that one of the members of the family and or one of the members of the family of your friends had/ has an Alzheimer’s disease?

The table shows that majority of the respondents knows what Alzheimer’s

disease is, consisting of 51 students or 85% and 9 students or 15% they

don’t know what Alzheimer’s disease is.

42 students or 70% knows the effects of Alzheimer’s disease and 18 or 30%

who doesn’t know the effects of Alzheimer’s disease. 31 or 52% who are

familiar with the causes of Alzheimer’s disease. Majority of the students

get the information about Alzheimer’s disease in their relatives, family

members, charts, ads, and TV.

Their reaction upon learning about the disease that one of the members

of their family and or one of the members of their family of their friends

had/ has an Alzheimer’s disease is that they will help them with everyday

lives. They’re scared to have that kind of disease and some says that they

feel pity because they will forget the happiest moment of their lives. This

signifies that only few of their members of their family and or one of the

members of their family of their friends had/ has an Alzheimer’s disease.

Chapter V

Summary of findings, conclusions, and recommendations

Summary of results and findings

Looking at the profile of the respondents, greater part of them is

aged 14-15.The respondents taken were mostly females, constituting 63%

of their total population.

Majority of the students or respondents get the information about

Alzheimer’s disease in their relatives, family members, charts, ads, and TV.

70% or 42 students who did answer my survey questionnaire seriously. 30%

or 18 students of MIAQC who DIDN’T answer my survey questionnaire

seriously.

Majority of the respondents knows what Alzheimer’s disease is,

consisting of 51 students or 85% and 9 students or 15% they don’t know

what Alzheimer’s disease is. 42 students or 70% knows the effects of

Alzheimer’s disease and 18 or 30% who doesn’t know the effects of

Alzheimer’s disease. 31 or 52% who are familiar with the causes of

Alzheimer’s disease. Majority of the students get the information about

Alzheimer’s disease in their relatives, family members, charts, ads, and TV.

Their reaction upon learning about the disease that one of the members

of their family and or one of the members of their family of their friends

had/ has an Alzheimer’s disease is that they will help them with everyday

lives.

They’re scared to have that kind of disease and some says that they feel

pity because they will forget the happiest moment of their lives. This

signifies that only few of their members of their family and or one of the

members of their family of their friends had/ has an Alzheimer’s disease

Conclusions

In light of the findings of the study, the following conclusions are made:

1. Alzheimer's disease (AD) is the most common form of dementia among older people. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities.

2. People with AD may have trouble remembering things that happened recently or names of people they know.

3. People may not recognize family members or have trouble speaking, reading or writing. They may forget how to brush their teeth or comb their hair.

4. Later on, they may become anxious or aggressive, or wander away from home. Eventually, they need total care. This can cause great stress for family members who must care for them.

5. AD usually begins after age 60. The risk goes up as you get older. Your risk is also higher if a family member has had the disease.

6. No treatment can stop the disease. However, some drugs may help keep symptoms from getting worse for a limited time.

7. Primary care physicians have an important role to play in acknowledging and supporting the care giving provided by family and friends to individuals with dementia.

Recommendations

One website recommends adopting a "brain-healthy diet" by "reducing

your intake of foods high in fat and cholesterol."

Bibliography

Habeck, M. "New Insights into Alzheimer's Disease." Drug Discovery Today, 2002, 7 (8): 441-442.

Holstein, M. "Alzheimer's Disease and Senile Dementia, 1885-1920: An Interpretive History of Disease Negot! iation." Journal of Aging Studies. 1996, 11 (1): 1-13.

Khachaturian, Z.S., Radebaugh, T.S., Alzheimer's Disease: Cause(s), Diagnosis, Treatment, and Care. New York: CRC Press, 1996.

Maccioni, R.B., Mu–oz, J.P., Barbeito, L. "The Molecular Bases of Alzheimer's Disease and Other Neurodegenerative Disorders." Archives of Medical Research. 2001, 32 (5): 367-381.

Toreilles, F., Touchon, J., "Pathogenic Theories and Intrathecal Analysis of the Sporadic form of Alzheimer's Disease." Progress in Neurobiology. 2002, 66: 191-203.

Whaley, Natalie S. "Senility, Confusion, Debate, Fear: Conceptualizing Alzheimer's Disease and the History of Senile Dementia." Thesis. Drew University, Madison, NJ, 2002.

Usita, P.M., Hyman, I.E. Jr., Herman, K.C. "Narrative Intentions: Listening to Life Stories in Alzheimer's Disease." Journal of Aging Studies. 1998, 12 (2): 185-197.

Sharon E. Rydon. (2005) The attitudes, knowledge and skills needed in mental health nurses: The perspective of users of mental health services*. International Journal of Mental Health Nursing 14:2, 78–87

L. Edman, J. Larsen, RN, PHD, CANDIDATE H. Hägglund, MD, PHD A. Gardulf, RN, PHD Assistant Professor. (2001) Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation. European Journal of Cancer Care 10:2, 124–130

Bonnie J. Nesbitt, Susan M. Heidrich. (2000) Sense of coherence and illness appraisal in older women's quality of life. Research in Nursing & Health 23:1, 25

Nicholas Holdsworth BA(Hons) MA RMN. (1995) From psychiatric science to folk psychology: an ordinary-language model of the mind for mental health nurses. Journal of Advanced Nursing 21:3, 476–486

Purandare, N, Oude Voshaar, R C, McCollum, C, Jackson, A, Burns, A (2008). Paradoxical embolisation and cerebral white matter lesions in dementia. Br. J. Radiol. 81: 30-34

Kivipelto, M., Solomon, A. (2006). Cerebral embolism and Alzheimer's disease.. BMJ 332: 1104-1105

Kovari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C., Giannakopoulos, P. (2007). Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementi

http://www.alzphilippines.com/aboutus.html

http://www.doh.gov.ph/faq/show/489

Caceres, A, Kosik, KS, Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons Nature. 1990. 343:461-463 2105469

Ebneth, A, et al.Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer’s disease J. Cell Biol. 1998. 143:777-794 9813097

Grundke-Iqbal, I, et al.Microtubule-associated protein tau. A component of Alzheimer paired helical filaments J. Biol. Chem. 1986. 261:6084-6089 3084478

Jicha, GA, Berenfeld, B, Davies, P, Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer’s disease J. Neurosci. Res. 1999. 55:713-723 10220112

Uboga, NV, Price, JL, Formation of diffuse and fibrillar tangles in aging and early Alzheimer’s disease Neurobiol. Aging. 2000. 21:1-10 10794842

Weaver, CL, Espinoza, M, Kress, Y, Davies, P, Conformational change as one of the earliest alterations of tau in Alzheimer’s disease Neurobiol. Aging. 2000. 21:719-727 11016541

Bramblett, GT, et al.Abnormal tau phosphorylation at Ser396 in Alzheimer’s disease recapitulates development and contributes to reduced microtubule binding Neuron. 1993. 10:1089-1099 8318230

Kerr, JF, Wyllie, AH, Currie, AR, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer. 1972. 26:239-257 4561027

Gervais, FG, et al.Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-beta precursor protein and amyloidogenic A beta peptide formation Cell. 1999. 97:395-406 10319819

Stadelmann, C, et al.Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer’s disease. Evidence for apoptotic cell death Am. J. Pathol. 1999. 155:1459-1466 10550301

Rohn, TT, Head, E, Nesse, WH, Cotman, CW, Cribbs, DH, Activation of caspase-8 in the Alzheimer’s disease brain Neurobiol. Dis. 2001. 8:1006-1016 11741396

Rohn, TT, et al.Correlation between caspase activation and neurofibrillary tang

le formation in Alzheimer’s disease Am. J. Pathol. 2001. 158:189-198 11141492

Su, JH, Zhao, M, Anderson, AJ, Srinivasan, A, Cotman, CW, Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology Brain Res. 2001. 898:350-357 11306022

Rohn, TT, et al.Caspase-9 activation and caspase cleavage of tau in the Alzheimer’s disease brain Neurobiol. Dis. 2002. 11:341-354 12505426[PubMed]

Gastard, MC, Troncoso, JC, Koliatsos, VE, Caspase activation in the limbic cortex of subjects with early Alzheimer’s disease Ann. Neurol. 2003. 54:393-398 12953274

Gamblin, TC, et al.Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer’s disease Proc. Natl. Acad. Sci. U. S. A. 2003. 100:10032-10037 12888622

Carmel, G, Mager, EM, Binder, LI, Kuret, J, The structural basis of monoclonal antibody Alz50’s selectivity for Alzheimer’s disease pathology J. Biol. Chem. 1996. 271:32789-32795 8955115

Curriculum Vitae

Personal Information

Name:

Hazzel Mae Mejias Cutora

Nickname:

Hazzel

Date of birth:

November 14, 1991

Place of birth:

Ubay, Bohol

Civil status:

Single

Height:

5"

Weight:

45 Kg.

Citizenship:

Filipino

Religion:

Roman Catholic

Educational Background

Elementary

Secondary Education

Tapon Elementary School

Our Lord’s Grace Montessori

Grades 1-4

Level 1-3

Trinity University of Asia

Mary Immaculate Academy of Q.C

Grades 5-6

Level IV










No comments: